The ITCC Strategy
Overarching goal : To accelerate the introduction of new effective and safe therapies in the treatment of children and adolescents with cancer
By means of :
• increasing the likelihood of entering/prioritizing potentially effective drugs in pediatric development based on science, increased knowledge of tumor biology and better preclinical evaluation
• speeding up the initiation of pediatric studies with regard to development in adults and the development of drugs specific to pediatric malignancies,
• speeding up the development of combinations
• speeding up implementation of new therapies in first line treatments of high risk diseases in order to increase the probability of curing more children more rapidly.
With:
• An innovative and outstanding scientific and medical research program that will be both tumor agnostic and disease-oriented,
• An effective and coordinated Industry strategy
• An innovative and outstanding scientific and medical research program that will be both tumor agnostic and disease-oriented,
• An effective and coordinated Industry strategy
Through :
1.stronger interactions between biological and clinical activities
2.effective cooperation with European Tumour Groups
3.introduction of new technologies and facilitated access to data, assets and platforms
4.strengthened international cooperation